<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04063345</url>
  </required_header>
  <id_info>
    <org_study_id>SAHZJU CT015</org_study_id>
    <nct_id>NCT04063345</nct_id>
  </id_info>
  <brief_title>Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction</brief_title>
  <acronym>LOVEinSTEMI</acronym>
  <official_title>A Prospective, Open Label, Multicenter and Randomized Study of Clinical Outcomes of Intravascular Ultrasound -Guided and Angiography-Guided Primary Percutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ningbo No. 1 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital of Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Xiamen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Chest Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taizhou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine the impact of IVUS guidance on clinical outcomes in the patient with Acute ST&#xD;
      Segment Elevated Myocardial Infarction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intravascular ultrasound (IVUS) has been increasingly used as a guide for percutaneous&#xD;
      coronary intervention (PCI) during elective as well as emergent clinical scenario. Recent&#xD;
      small number randomized studies, large scale registries as well as meta-analysis have&#xD;
      consistently demonstrated advantages of IVUS-guidance over angiography-guide alone with&#xD;
      respect to the lower incident of death, myocardial infarction and target vessel&#xD;
      revascularization.&#xD;
&#xD;
      There are sparse data available on the clinical impact of IVUS-guided PCI in the setting of&#xD;
      acute myocardial infarction (AMI) and its use remains a matter of controversy as shown by&#xD;
      previous studies. This study is to examine the impact of IVUS guidance on clinical outcomes&#xD;
      in the patient with Acute ST Segment Elevated Myocardial Infarction (STEMI).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac event (MACE) rate</measure>
    <time_frame>1 year</time_frame>
    <description>Defined as cardiac death, myocardial infarction (MI, Q-wave and non-Q-wave) and target vessel revascularization (TVR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization (TLR) rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion failure (TLF) rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TVR rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure (TVF) rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MI (Q-wave and non-Q-wave) rat</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-cardiac death rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All death (cardiac and non-cardiovascular) rate</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis (ST) rate (ARC definite/probable)</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous intervention under IVUS-guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Angiography-guided PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Percutaneous intervention under angiograhy-guidance only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IVUS-guided PCI</intervention_name>
    <description>Performing intravascular ultrasound before or/and after percutaneous intervention</description>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Angiography-guided PCI</intervention_name>
    <description>Performing percutaneous intervention without intravascular ultrasound guidance</description>
    <arm_group_label>Angiography-guided PCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical inclusion criteria:&#xD;
&#xD;
               1. Age &gt; 18 years&#xD;
&#xD;
               2. Onset of STEMI &gt; 30 minutes, but &lt; 12 hours&#xD;
&#xD;
               3. ST segment elevation in at least 2 contiguous leads of≥ 1mm or newly developed&#xD;
                  LBBB on ECG&#xD;
&#xD;
               4. Willing and able to provide informed consent&#xD;
&#xD;
          -  Angiographic inclusion criteria:&#xD;
&#xD;
               1. Having at least one infarct-related coronary artery, of which (1) the Culprit&#xD;
                  lesion is suitable for stenting (2) the reference diameter of culprit vessel is ≥&#xD;
                  2.5 mm but ≤ 4 mm (3) the TIMI flow is ≤ 1 in culprit lesion segment prior to&#xD;
                  guide wire crossing&#xD;
&#xD;
               2. No excessive tortuosity and calcification in the culprit lesion segment that&#xD;
                  allowing stent implantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical exclusion criteria:&#xD;
&#xD;
               1. Contraindicating to any concomitant study medications&#xD;
&#xD;
               2. Having cardiogenic shock with hemodynamic instability&#xD;
&#xD;
               3. A history of bleeding diathesis or known coagulopathy&#xD;
&#xD;
               4. A history of cerebrovascular accident (CVA) or transient ischemic attack (TIA)&#xD;
                  within the past 6 months; or a history of intracranial tumor, aneurysm or&#xD;
                  arteriovenous malformations; or a history of active peptic ulcer or active&#xD;
                  gastrointestinal (GI) bleeding within the past 2 months; or planned major&#xD;
                  procedure within 6 weeks; or known platelet count &lt; 100,000 /mm3 or Hb &lt; 10 g/dL&#xD;
&#xD;
               5. Planned surgery which may cause discontinuation of ADP-receptor antagonist&#xD;
&#xD;
               6. Other serious illness (e.g., cancer) that may reduce life expectancy to less than&#xD;
                  1 year&#xD;
&#xD;
               7. Repeated MI within 7 days of hospitalization for acute MI&#xD;
&#xD;
          -  Anigographic Exclusion Criteria:&#xD;
&#xD;
               1. Bifurcated lesion unable to identify the culprit lesion&#xD;
&#xD;
               2. The culprit lesion is located in the left main artery&#xD;
&#xD;
               3. Diffusive lesions without distinguishable culprit lesion&#xD;
&#xD;
               4. Previous stent implantation in the culprit lesion segment or STEMI caused by&#xD;
                  stent thrombosis&#xD;
&#xD;
               5. Likely CABG procedure within 30 days&#xD;
&#xD;
               6. Renal failure requiring or during dialysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jian-an Wang, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Second Affiliated Hospital of Zhejiang University, School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jun Jiang, MD, PhD</last_name>
    <phone>+86-13588706891</phone>
    <email>drjayj@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Liang Dong, MD, PhD</last_name>
    <phone>+86-13858188861</phone>
    <email>chenhaibo1030@zju.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Second affiliated Hospital Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Jun Jiang, MD, PhD</last_name>
      <phone>+86-13588706891</phone>
      <email>drjayj@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 19, 2019</study_first_submitted>
  <study_first_submitted_qc>August 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2019</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STEMI</keyword>
  <keyword>Intravascular ultrasound</keyword>
  <keyword>Angiography</keyword>
  <keyword>Primary percutaneous intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

